This company has been marked as potentially delisted and may not be actively trading. Intensity Therapeutics, Inc. Common stock (INTS) Institutional Ownership Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsCompetitorsEarningsHeadlinesOwnershipShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Intensity Therapeutics, Inc. Common stock (NASDAQ:INTS)CurrentInstitutional OwnershipPercentage3.74%Number ofInstitutional Buyers(last 12 months)6TotalInstitutional Inflows(last 12 months)$587.94KNumber ofInstitutional Sellers(last 12 months)3TotalInstitutional Outflows(last 12 months)$200.83K Get INTS Insider Trade Alerts Want to know when executives and insiders are buying or selling Intensity Therapeutics, Inc. Common stock stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data INTS Institutional Buying and Selling by Quarter Intensity Therapeutics, Inc. Common stock Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails4/15/2025 Sapient Capital LLC976,797$1.92M0.0%+3.6%6.469% 2/18/2025GTS Securities LLC19,030$34K0.0%-49.0%0.126% 2/17/2025Citadel Advisors LLC14,964$26K0.0%N/A0.099% 2/7/2025Mesirow Financial Investment Management Inc.20,000$35K0.0%-54.7%0.132% 2/3/2025Sigma Planning Corp54,837$97K0.0%+14.9%0.363% 1/29/2025 Sapient Capital LLC942,841$1.66M0.0%-6.7%6.244% 11/16/2024Geode Capital Management LLC64,349$246K0.0%+35.1%0.467% 8/12/2024Blair William & Co. IL37,805$185K0.0%N/A0.276% 4/26/2024Mesirow Financial Investment Management Inc.44,177$230K0.0%N/A0.322% 4/23/2024 Sapient Capital LLC1,012,069$5.26M0.1%+406.0%7.382% 2/9/2024Hohimer Wealth Management LLC44,779$384K0.1%-76.0%0.327% 2/6/2024 Sapient Capital LLC200,000$1.71M0.0%N/A1.459% 2/1/2024Sigma Planning Corp34,443$295K0.0%-28.5%0.251% 1/29/2024 Sapient Capital LLC200,000$1.71M0.1%N/A1.459% 11/21/2023Hohimer Wealth Management LLC186,464$740K0.2%N/A1.360% 11/6/2023Sigma Planning Corp48,144$191K0.0%N/A0.352% (Data available from 1/1/2016 forward) INTS Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of INTS shares? During the previous two years, the following institutional investors and hedge funds held shares of Intensity Therapeutics, Inc. Common stock shares: Sapient Capital LLC ($1.92M), Hohimer Wealth Management LLC ($384K), Geode Capital Management LLC ($246K), Blair William & Co. IL ($185K), Sigma Planning Corp ($97K), Mesirow Financial Investment Management Inc. ($35K), and GTS Securities LLC ($34K).Learn more on INTS's institutional investors. What percentage of Intensity Therapeutics, Inc. Common stock stock is owned by institutional investors? 3.74% of Intensity Therapeutics, Inc. Common stock stock is owned by institutional investors. Learn more on INTS's institutional investor holdings. Which institutional investors have been buying Intensity Therapeutics, Inc. Common stock stock? The following institutional investors have purchased Intensity Therapeutics, Inc. Common stock stock in the last 24 months: Sapient Capital LLC ($1.25M), Hohimer Wealth Management LLC ($186.46K), Sigma Planning Corp ($55.24K), Mesirow Financial Investment Management Inc. ($44.18K), Blair William & Co. IL ($37.81K), Geode Capital Management LLC ($16.73K), and Citadel Advisors LLC ($14.96K). How much institutional buying is happening at Intensity Therapeutics, Inc. Common stock? Institutional investors have bought a total of 1,601,401 shares in the last 24 months. This purchase volume represents approximately $9.17M in transactions. Which Intensity Therapeutics, Inc. Common stock major shareholders have been selling company stock? The following institutional investors have sold Intensity Therapeutics, Inc. Common stock stock in the last 24 months: Hohimer Wealth Management LLC ($141.69K), Sapient Capital LLC ($67.91K), Mesirow Financial Investment Management Inc. ($24.18K), GTS Securities LLC ($18.26K), and Sigma Planning Corp ($13.70K). How much institutional selling is happening at Intensity Therapeutics, Inc. Common stock? Institutional investors have sold a total of 265,733 shares in the last 24 months. This volume of shares sold represents approximately $1.53M in transactions. Related Companies CGEN Institutional Ownership CHRS Institutional Ownership FATE Institutional Ownership KOD Institutional Ownership EDIT Institutional Ownership NMRA Institutional Ownership TIL Institutional Ownership ALEC Institutional Ownership KYTX Institutional Ownership CCCC Institutional Ownership This page (NASDAQ:INTS) was last updated on 4/27/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored"I'm risking my reputation on this"I've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredTrump’s tariffs just split the AI market in twoTrump’s tariff just split the AI market – among others – in two. One group of AI companies—the ones relying...Traders Agency | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Intensity Therapeutics, Inc. Common stock Please log in to your account or sign up in order to add this asset to your watchlist. Share Intensity Therapeutics, Inc. Common stock With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
